Legal Opinion
Novartis Ag v. Noven Pharmaceuticals Inc.
Court of Appeals for the Federal Circuit
Decided April 4, 2017No. 2016-1678; 2016-1679PublishedCited by 3 opinions
1Opinion of the Court
WALLACH, Circuit Judge.
The instant appeals concern inter partes reviews of U.S. Patent Nos. 6,316,023 (“the ’023 patent”) and 6,335,031 (“the ’031 patent”) (together, “the Patents-in-Suit”). In two separate final written decisions, the U.S. Patent and Trademark Office’s (“USPTO”) Patent Trial and Appeal Board (“PTAB”) found that various claims of the Patents-in-Suit (“the Asserted Claims”) 1 would have been obvious over the prior art. See Noven Pharm., Inc. v. Novartis AG (Noven I), No. IPR2014-00549, 2015 WL 5782080, at *23 (P.T.A.B. Sept. 28, 2015) (finding the disputed claims of the ’023…
2Cases cited13 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- Burlington Truck Lines, Inc. v. United StatesSupreme Court of the United States · 1962
- United States v. AdamsSupreme Court of the United States · 1966
- In Re Robert J. Gartside and Richard C. NortonCourt of Appeals for the Federal Circuit · 2000
- Cuozzo Speed Technologies, LLC v. LeeSupreme Court of the United States · 2016
8 more not listed; retrieve them via the Exa API.
3Cited by3 opinions
- Georgetown Rail Equipment Co. v. Holland L.P.Court of Appeals for the Federal Circuit · 2017
- Jones v. Secretary of Health and Human ServicesUnited States Court of Federal Claims · 2020
- Liqwd, Inc. v. L'Oreal USA, Inc.Court of Appeals for the Federal Circuit · 2019